Amazon, Berkshire Hathaway, and JPMorgan Chase caused quite the stir Tuesday with news of a new venture aimed at providing their U.S. employees with "simplified, high-quality, and transparent healthcare at a reasonable cost." But what does this actually mean for the medical device and diagnostic industry?
News & Features
It's too soon to tell if the FCC's recent vote to end net neutrality regulations will have ramifications for telemedicine and connected health, but here are some of the possibilities.
MIT researchers are working on a new technology that could convert text to speech for visually impaired users.
The organizers of Cardiostim, a meeting focused on electrophysiology and cardiac techniques, have pulled the plug, just months before the event's 40th anniversary was to be held in Nice, France.
Two companies have landed grants from JDRF to support the development of insulin delivery devices that are small enough for children to wear comfortably.
In the annual ranking of the top medical device and diagnostics companies by revenue, some companies climbed up a few spots, while others fell behind. We rounded up the biggest gainers and losers.
Intuitive Surgical has ramped up product development spending in recent months to prepare for new entrants to the surgical robot market.
Stanford researchers aim to simplify HIV testing and boost early detection rates through a saliva-based test.
Abbott enjoyed a strong finish to 2017 and, if the company's fourth-quarter earnings call is any indication, 2018 could be even better.
Boston Scientific has taken a $90 million stake in Millipede, the developer of a transcatheter annuloplasty ring system, with an option to acquire the remaining shares.
A Pharmapack 2018 speaker explains a new needle-free approach that could suit biologics and support digital health.